DNA Group (TR) Ltd

XTAE:DNA (Israel)  
₪ 0.87 (-4.6%) Jun 4
At Loss
P/B:
1.38
Market Cap:
₪ 107.28M ($ 29.05M)
Enterprise V:
₪ 40.58M ($ 10.99M)
Volume:
193.05K
Avg Vol (2M):
152.45K
Volume:
193.05K
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for DNA Group (TR) Ltd ( XTAE:DNA ) from 2007 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. DNA Group (TR) stock (XTAE:DNA) PE ratio as of Jun 05 2024 is 0. More Details

DNA Group (TR) Ltd (XTAE:DNA) PE Ratio (TTM) Chart

To

DNA Group (TR) Ltd (XTAE:DNA) PE Ratio (TTM) Historical Data

Total 1249
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
DNA Group (TR) PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 At Loss 2024-04-02 At Loss
2024-06-04 At Loss 2024-04-01 At Loss
2024-06-03 At Loss 2024-03-31 At Loss
2024-06-02 At Loss 2024-03-28 At Loss
2024-05-30 At Loss 2024-03-27 At Loss
2024-05-29 At Loss 2024-03-26 At Loss
2024-05-28 At Loss 2024-03-25 At Loss
2024-05-27 At Loss 2024-03-24 At Loss
2024-05-26 At Loss 2024-03-21 At Loss
2024-05-23 At Loss 2024-03-20 At Loss
2024-05-22 At Loss 2024-03-19 At Loss
2024-05-21 At Loss 2024-03-18 At Loss
2024-05-20 At Loss 2024-03-17 At Loss
2024-05-19 At Loss 2024-03-14 At Loss
2024-05-16 At Loss 2024-03-13 At Loss
2024-05-15 At Loss 2024-03-12 At Loss
2024-05-14 At Loss 2024-03-11 At Loss
2024-05-13 At Loss 2024-03-10 At Loss
2024-05-12 At Loss 2024-03-07 At Loss
2024-05-09 At Loss 2024-03-06 At Loss
2024-05-08 At Loss 2024-03-05 At Loss
2024-05-07 At Loss 2024-03-04 At Loss
2024-05-06 At Loss 2024-03-03 At Loss
2024-05-05 At Loss 2024-02-29 At Loss
2024-05-02 At Loss 2024-02-28 At Loss
2024-05-01 At Loss 2024-02-27 At Loss
2024-04-30 At Loss 2024-02-26 At Loss
2024-04-29 At Loss 2024-02-25 At Loss
2024-04-28 At Loss 2024-02-22 At Loss
2024-04-25 At Loss 2024-02-21 At Loss
2024-04-24 At Loss 2024-02-20 At Loss
2024-04-23 At Loss 2024-02-19 At Loss
2024-04-22 At Loss 2024-02-18 At Loss
2024-04-21 At Loss 2024-02-15 At Loss
2024-04-18 At Loss 2024-02-14 At Loss
2024-04-17 At Loss 2024-02-13 At Loss
2024-04-16 At Loss 2024-02-12 At Loss
2024-04-15 At Loss 2024-02-11 At Loss
2024-04-14 At Loss 2024-02-08 At Loss
2024-04-11 At Loss 2024-02-07 At Loss
2024-04-10 At Loss 2024-02-06 At Loss
2024-04-09 At Loss 2024-02-05 At Loss
2024-04-08 At Loss 2024-02-04 At Loss
2024-04-04 At Loss 2024-02-01 At Loss
2024-04-03 At Loss 2024-01-31 At Loss

DNA Group (TR) Ltd (XTAE:DNA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
DNA Group (TR) Ltd invests in biomed companies and has also started to engage in profitable real estate in England.